Lipid-based CVD score targets ‘troubling’ intermediate-risk patients
But the score needs more testing before widespread use in clinical practice, says Emeritus Professor Mark Harris.
Australian doctors have created a lipid-based risk score to help manage the ‘troubling group’ of patients at intermediate risk of CVD.
Based on a routine blood test, the new score provides better cardiovascular risk stratification for those in the intermediate zone than the outdated Framingham-based equation, according to the Baker Heart and Diabetes Institute-led team.
